Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Spencer Stuart/Directors & Boards Directors Roster. (A-G).
- 1-800-FLOWERS.COM 1600 Stewart Avenue, Westbury, NY 11590 has added to its board: Mary Lou Quinlan Chief Executive Officer JUST ASK A WOMAN 79 Madison Avenue, 5th Floor, New York, NY 10016 ...
- Research articles 2002-06-22
- Barr challenge
- Barr Laboratories Inc. has been sued by Akzo Nobel and its pharmaceutical unit, Organon Inc. The action is in response to Barr's challenge of patents protecting Remeron SolTab, an orally disintegrating tablet for depression.
- Research articles 2002-06-10
- Active Pharmaceutical ingredient watch. (Markets).(Brief Article)
- ABBOTT Laboratories and NaPro Bio Therapeutics Inc. have received FDA approval to market paclitaxel injection, the generic equivalent of Bristol-Myers Squibb Company's anticancer compound Taxol. AKZO Nobel's Organon Inc. has filed suit in a federal district court against Barr Laboratories Inc. for...
- Research articles 2002-05-13
- Issues Remain for Warfarin
- NEW YORK -- A federal judge in Wilmington, Del., dismissed a claim by Barr Laboratories Inc. that DuPont Pharmaceuticals violated federal antitrust law in advocating before state legislatures patients' right to know which kind of warfarin, an anticoagulant medication, they have been prescribed. But in Virginia the state pharmacy...
- Research articles 1999-01-18
Additional Resources
- Supreme Court rejects Lilly appeal. (News).(Barr Laboratories Inc. to begin marketing a generic version of Eli Lilly & Co.'s Prozac antidepressant)(Brief Article)
- THE SUPREME COURT last week rejected Eli Lilly & Co.'s appeal of a patent ruling that allows Barr Laboratories Inc. to begin marketing a generic version of Prozac, a blockbuster antidepressant drug. The justices upheld a federal appeals c ...
- Research articles 2002-01-21
- BARR Laboratories, Inc.(receives tentative Food and Drug Administration approval for oral contraceptive)(Brief Article)
- BARR Laboratories, Inc. has been granted tentative approval by the FDA for the manufacture and ... BARR Laboratories, Inc. has been granted tentative approval by the FDA for the manufacture and marketing of its generic version of Ortho-McNeil Pharmaceutical's Ortho-Novum 7/7/7 oral contraceptive. ...
- Research articles 2001-03-19
- Kos Sues Barr Labs. (Markets: Life Sciences).(Kos Pharmaceuticals Inc. sues Barr Laboratories Inc.)(Brief Article)
- KOS PHARMACEUTICALS Inc. has filed a patent infringement lawsuit in a federal district court against Barr Laboratories Inc. over the $36 million cholesterol drug Niaspan niacin. Kos holds two patents, expiring in 2013 and 2017, on Niaspan once-daily extended release 1,000 mg...
- Research articles 2002-03-11
- Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc
- EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Barr Laboratories, Inc., a wholly-owned subsidiary of Barr Pharmaceuticals, Inc., (NYSE: BRL) for infringement of Savient's U.S. Patent Nos. 5,872,147 ("the...
- Research articles 2006-09-26
- New ratings on Charter One Financial, Jb Hunt Transport Svcs, Ryland Group Inc. The, Silicon Storage Tech Inc, Barr Laboratories Inc.
- M2 PRESSWIRE-6 June 2002-StockPickReport.Com: New ratings on Charter One Financial, Jb Hunt Transport Svcs, Ryland Group Inc. The, Silicon Storage Tech Inc, Barr Laboratories Inc C1994-2002 M2 COMMUNICATIONS LTD RDATE:06052002 StockPickReport.Com (IARD#119079 - http://www.stockpickreport.com/?src=n3 ) makes these...
- Research articles 2002-06-06
- Barr Laboratories Inc. (Active Pharmaceutical Ingredient Watch).(fourth quarter earnings report)(Brief Article)(Statistical Data Included)
- BARR LABORATORIES Inc. posted fourth quarter 2002 net profit of $44.9 million, or 98 cents per share, up 56 percent, and 11 cents above Banc of America Securities analyst Timothy Chiang's estimates, on sales up 27 percent to $209 million. The company expects to earn between ...
- Research articles 2002-08-19
- Alert -- Rating change for Kimberly Clark Corp, Dollar General Corp, Barr Laboratories Inc, Internat Rectifier Corp, Lamar Advertising Co A.
- M2 PRESSWIRE-17 May 2002-EquityOutlook.Com: Alert -- Rating change for Kimberly Clark Corp, Dollar General Corp, Barr Laboratories Inc, Internat Rectifier Corp, Lamar Advertising Co A C1994-2002 M2 COMMUNICATIONS LTD RDATE:05172002 EquityOutlook.Com (IARD#118718) - www.equityoutlook.com - evaluates the following stocks:...
- Research articles 2002-05-17
- Aventis, Barr Battle Over Generic Allegra.(Barr Laboratories, Aventis Pharma)(Brief Article)
- BARR LABORATORIES Inc. plans to challenge the patents protecting Allegra fexofenadine, the anti-allergy drug by Aventis Pharma AG. The action follow Barr's filing of an abbreviated new drug application ANDA with the Food & Drug Administrati BARR LABORATORIES Inc. plans to challenge the patents...
- Research articles 2001-07-09
- ADDERALL XR(R) - Shire Files Legal Suit Against Barr Laboratories and Impax Laboratories for Infringement of U.S. Patent No. 6,913,768.
- BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, October 20 /PRNewswire/ -- Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that its subsidiary Shire Laboratories Inc. has filed a lawsuit in the U.S. District Court of the Southern District of New York...
- Research articles 2005-10-20
- Barr, Mylan Report Strong Quarterly Results.(Barr Laboratories)(Brief Article)(Statistical Data Included)
- BARR LABORATORIES Inc. reported solid first quarter fiscal 2002 earnings, beating analysts' estimates on sales of its generic Prozac fluoxetine and breast cancer drug tamoxifen. Barr completed its merger with Duramed Pharmaceuticals Inc., accretive to 2003, which also reported solid third quarter earnings. ...
- Research articles 2001-10-29
- CIMA LABS Announces That Akzo Nobel And Organon Inc. Have Filed Patent Infringement Suit Against Barr Laboratories
- Business Editors EDEN PRAIRIE, Minn.--BUSINESS WIRE--May 3, 2002 CIMA LABS INC. (Nasdaq:CIMA) today announced that Akzo Nobel NV (Nasdaq:AKZOY) and its Organon Inc. pharmaceutical unit filed suit in the Federal District Court of Newark, N.J., today against Barr Laboratories, Inc. (NYSE:BRL), claiming that Barr has infringed on the...
- Research articles 2002-05-03
- Mack-Cali Leases Entire Building to Barr Laboratories; Pharmaceutical Firm to Relocate Executive Offices to Woodcliff Lake Property
- Business Editors CRANFORD, N.J.--BUSINESS WIRE--Feb. 13, 2003 Mack-Cali Realty Corporation (NYSE: CLI) today announced it has leased an entire office building in Woodcliff Lake, New Jersey to Barr Laboratories, Inc. The pharmaceutical firm will relocate its executive offices from Blauvelt, New York, to the property, located at 400...
- Research articles 2003-02-13
- Shire Pharmaceuticals Group PLC - Shire Files Legal Suit against Barr and Impax.
- ADDERALL XRA' - Shire Files Legal Suit against Barr Laboratories and Impax Laboratories for Infringement of U.S. Patent No. 6,913,768 Basingstoke, UK and Philadelphia, US - October 20, 2005 - Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that its subsidiary ...
- Research articles 2005-10-20
- Leerink Swann & Company Initiates Coverage of Barr Pharmaceuticals, Inc. (NYSE: BRL) Mylan Laboratories Inc. (NYSE: MYL)
- This morning, Senior Generic Pharmaceutical Analyst, William F. Sawyer, initiated coverage of Barr Pharmaceuticals (NYSE: BRL) with an Outperform rating and Mylan Laboratories Inc. (NYSE: MYL) with a Market Perform rating. He bases his investment rating for Barr on his view that solid operating performance from Barr's generic and branded...
- Research articles 2005-12-16
- Barr to fight FDA Nolvadex ruling. (Life Sciences).(Brief Article)(Statistical Data Included)
- BARR Laboratories Inc. has encountered a hurdle in its race to market a generic version of AstraZeneca PLC AZ's breast cancer drug Nolvadex tamoxifen. Last week, the Food and Drug Administration FDA retroactively altered the approval da BARR...
- Research articles 2002-09-30
- Barr Labs, DuPont Pharma Form Alliance.(Brief Article)
- BARR LABORATORIES INC. and DuPont Pharmaceuticals Company have signed a letter of intent to create a broad strategic relationship to develop, market and promote five different proprietary products. DuPont will invest up to $45 million in devel BARR LABORATORIES...
- Research articles 2000-01-24
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
